Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ovarian Cancer, Ovarian Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT06232863
What this trial is testing

BH009 in Head and Neck Squamous Cell Carcinoma and Ovarian Cancer

Who this might be right for
Solid Tumor, Adult
Zhuhai Beihai Biotech Co., Ltd 24
Testing effectiveness (Phase 2)UnknownNCT06308406
What this trial is testing

A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian Cancer

Who this might be right for
Recurrent Ovarian Cancer
Jiangsu HengRui Medicine Co., Ltd. 54
Testing effectiveness (Phase 2)Study completedNCT01653912
What this trial is testing

Dose-finding Study in Platinum-Resistant Ovarian Cancer

Who this might be right for
Recurrent Platinum-resistant Ovarian Cancer
Accenture 59
Large-scale testing (Phase 3)Study completedNCT02477644
What this trial is testing

Platine, Avastin and OLAparib in 1st Line

Who this might be right for
Ovarian Cancer
Arcagy Research 806
Not applicableStudy completedNCT04902144
What this trial is testing

Clinical Outcomes for Offering Genetic Testing in a Tiered Approach

Who this might be right for
Breast CarcinomaColon CarcinomaMalignant Solid Neoplasm+3 more
Fred Hutchinson Cancer Center 6
Not applicableLooking for participantsNCT06902467
What this trial is testing

Combined Intraperitoneal Chemotherapy Regimen After Optimal Interval Surgery in Advanced Ovarian Cancer: BICOV-1 (Bidirectional Chemotherapy in Ovarian Cancer)

Who this might be right for
Ovarian Cancer
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia 20
Not applicableWithdrawnNCT00460200
What this trial is testing

Depression and Interleukin-6 Production in Patients With Ovarian Epithelial Cancer

Who this might be right for
DepressionFatigueOvarian Cancer+2 more
Jonsson Comprehensive Cancer Center
Not applicableLooking for participantsNCT06640348
What this trial is testing

Ultrasensitive SERS Platform With Highly Efficient Enrichment of Analyte for Screening and Diagnosis of Epithelial Ovarian Cancer

Who this might be right for
Ovarian Cancer, Epithelial
Anhui Provincial Hospital 70
Not applicableWithdrawnNCT03703115
What this trial is testing

The Effect of Fasting on ICSI Outcomes in Patients With Polycystic Ovary Syndrome

Who this might be right for
InfertilityPolycystic Ovary Syndrome
Cairo University
Not applicableUnknownNCT05693974
What this trial is testing

Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Retrospective Study)

Who this might be right for
Ovarian Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 130
Early research (Phase 1)Study completedNCT02418624
What this trial is testing

Phase I of Carboplatin-Olaparib Followed by Olaparib Monotherapy in Advanced Cancer

Who this might be right for
Breast CancerOvarian CancerAdvanced Cancer
The Netherlands Cancer Institute 25
Testing effectiveness (Phase 2)Study completedNCT00059787
What this trial is testing

Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma

Who this might be right for
Brenner TumorFallopian Tube CancerOvarian Clear Cell Cystadenocarcinoma+6 more
National Cancer Institute (NCI) 56
Testing effectiveness (Phase 2)Study completedNCT05007106
What this trial is testing

MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)

Who this might be right for
Uterine Cervical NeoplasmsEndometrial NeoplasmsSquamous Cell Carcinoma of Head and Neck+8 more
Merck Sharp & Dohme LLC 613
Not applicableStudy completedNCT02172638
What this trial is testing

Postoperatory Recovery in Advanced Ovarian Cancer, Fast-Track Protocol vs. Classical Management

Who this might be right for
Median Length of StayReadmission RateSurgery Related Complications Rate+1 more
Hospital Universitari Vall d'Hebron Research Institute 110
Testing effectiveness (Phase 2)Looking for participantsNCT07447050
What this trial is testing

Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial

Who this might be right for
Breast CancerSarcomaGastric (Stomach) Cancer+7 more
University of California, Irvine 24
Testing effectiveness (Phase 2)Looking for participantsNCT05200260
What this trial is testing

Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
Shanghai Gynecologic Oncology Group 220
Testing effectiveness (Phase 2)Looking for participantsNCT05773859
What this trial is testing

NEOadjuvant Dendritic Cell Vaccination for Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerOvarian Carcinoma
Radboud University Medical Center 10
Early research (Phase 1)Study completedNCT01155258
What this trial is testing

Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors

Who this might be right for
Extensive Stage Small Cell Lung CancerHereditary ParagangliomaMale Breast Cancer+45 more
University of Southern California 19
Not applicableStudy completedNCT02544776
What this trial is testing

Amlodipine on Blood Flow of Preovulatory Follicle in Polycystic Ovarian Patients

Who this might be right for
Female Infertility Associated With Anovulation
Ahmed Fathy Ali Mohamed Ghanem 60
Early research (Phase 1)Active Not RecruitingNCT03875820
What this trial is testing

Phase I Trial of Defactinib and VS-6766.

Who this might be right for
NSCLCLow Grade Serous Ovarian CancerEndometrioid Carcinoma+1 more
Institute of Cancer Research, United Kingdom 87
Next Page